ROS1 and Genetic thrombotic microangiopathy: Several authors reported a heightened thromboembolic risk of ROS-1-rearranged tumors compared with NSCLCs harboring non-rearranged ROS-1 [30], and even rarer cases of thrombotic microangiopathies [31] and disseminated intravascular coagulation [32].